Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,951 public trials 2,018 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, Not Recruiting

Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

NCT03842696

Conditions
Acute Leukemia in Remission, Blast Crisis, Bone Marrow Diseases, +37 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • Emory University Atlanta, Georgia, United States
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • University of Michigan Health System Ann Arbor, Michigan, United States
View Trial Details
Active, Not Recruiting

Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors

NCT05071209

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +23 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Medical Center-Mission Bay San Francisco, California, United States
View all 29 locations
View Trial Details
Active, Not Recruiting

Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65

NCT01208662

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arizona Comprehensive Cancer Center Tucson, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California at San Diego La Jolla, California, United States
View all 46 locations
View Trial Details
Active, Not Recruiting

A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple Myeloma

NCT02718833

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Mass General/North Shore Cancer Center Danvers, Massachusetts, United States
  • Newton-Wellesley Hospital Newton, Massachusetts, United States
View Trial Details
Active, Not Recruiting

A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

NCT05023980

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
Locations
  • California Research Institute Los Angeles, California, United States
  • Innovative Clinical Research Institute Whittier, California, United States
  • Oncology-Hematology Associates of West Broward Coral Springs, Florida, United States
  • New Jersey Center for Cancer Research Brick, New Jersey, United States
View all 108 locations
View Trial Details
Active, Not Recruiting

Communication Skills Intervention to Promote Transition Into Survivorship

NCT01483664

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations
  • Tampa General Hospital Tampa, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States
  • Maimonides Medical Center Brooklyn, New York, United States
View Trial Details

Related conditions